Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


St. Jude sues Volcano Corp.

This article was originally published in The Gray Sheet

Executive Summary

St. Jude Medical alleges that several products developed by Volcano, including its PrimeWire pressure guide wire products, infringe on five patents used for St. Jude's PressureWire technology platform, which was acquired from Radi Medical Systems in December 2008 (1"The Gray Sheet" Jan. 5, 2009). Two other St. Jude Medical affiliates are also plaintiffs, according to the firm. The suit, which St. Jude announced on July 27, is filed in the U.S. District Court for the District of Delaware and seeks injunctive relief and monetary damages

You may also be interested in...

Holiday Shopping: St. Jude Adds To A-Fib, Cardio Units With Two Acquisitions

St. Jude Medical acquired two privately-held firms just before the New Year for a total of $550 million, gaining tools for artery lesion assessment and precise interventional procedure navigation, among other technologies

Celltrion Makes Progress On Coronavirus Treatment

Celltrion has accelerated the development of its antiviral treatment for COVID-19 and aims to launch a rapid self-testing kit that could provide results within 15-20 minutes. The Korean firm also plans to develop a ‘super antibody’ to prepare for potential future pandemic situations.

Spain Lists Certain OTCs As 'Essential' In Fight Against COVID-19

Paracetamol, acetylcysteine and loperamide among list of OTC drugs deemed "essential" by Spain in the fight against coronavirus.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts